-
3
-
-
34147137671
-
Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease
-
Beltroy E. P. Liu B. Dietschy J. M. Turley S. D. (2007). Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease. J Lipid Res 48, 869–81.
-
(2007)
J Lipid Res
, vol.48
, pp. 869-881
-
-
Beltroy, E.P.1
Liu, B.2
Dietschy, J.M.3
Turley, S.D.4
-
4
-
-
74949133999
-
A strategy for risk management of drug-induced phospholipidosis
-
Chatman L. A. Morton D. Johnson T. O. Anway S. D. (2009). A strategy for risk management of drug-induced phospholipidosis. Toxicol Pathol 37, 997–1005.
-
(2009)
Toxicol Pathol
, vol.37
, pp. 997-1005
-
-
Chatman, L.A.1
Morton, D.2
Johnson, T.O.3
Anway, S.D.4
-
6
-
-
0021958402
-
Increased hepatic density and phospholipidosis due to amiodarone
-
Goldman I. S. Winkler M. L. Raper S. E. Barker M. E. Keung E. Goldberg H. I. Boyer T. D. (1985). Increased hepatic density and phospholipidosis due to amiodarone. Am J Roentgenol 144, 541–6.
-
(1985)
Am J Roentgenol
, vol.144
, pp. 541-546
-
-
Goldman, I.S.1
Winkler, M.L.2
Raper, S.E.3
Barker, M.E.4
Keung, E.5
Goldberg, H.I.6
Boyer, T.D.7
-
7
-
-
0023813555
-
Amiodarone-induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease
-
Guigui B. Perrot S. Berry J. P. Fleury-Feith J. Martin N. Métreau J. M. Dhumeaux D. Zafrani E. S. (1988). Amiodarone-induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease. Hepatology 8, 1063–8.
-
(1988)
Hepatology
, vol.8
, pp. 1063-1068
-
-
Guigui, B.1
Perrot, S.2
Berry, J.P.3
Fleury-Feith, J.4
Martin, N.5
Métreau, J.M.6
Dhumeaux, D.7
Zafrani, E.S.8
-
8
-
-
0025649285
-
Human accumulation potential of xenobiotics: Potential of catamphiphilic drugs to promote their accumulation via inducing lipidosis or mucopolysaccharidosis
-
Hein L. Lüllmann-Rauch R. Mohr K. (1990). Human accumulation potential of xenobiotics: Potential of catamphiphilic drugs to promote their accumulation via inducing lipidosis or mucopolysaccharidosis. Xenobiotica 20, 1259–67.
-
(1990)
Xenobiotica
, vol.20
, pp. 1259-1267
-
-
Hein, L.1
Lüllmann-Rauch, R.2
Mohr, K.3
-
10
-
-
0025929868
-
Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats
-
Kannan R. Sarma J. S. Guha M. Venkataraman K. (1991). Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats. Fundam Appl Toxicol 16, 103–9.
-
(1991)
Fundam Appl Toxicol
, vol.16
, pp. 103-109
-
-
Kannan, R.1
Sarma, J.S.2
Guha, M.3
Venkataraman, K.4
-
11
-
-
0033145510
-
Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport
-
Kobayashi T. Beuchat M. H. Lindsay M. Frias S. Palmiter R. D. Sakuraba H. Parton R. G. Gruenberg J. (1999). Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1, 113–8.
-
(1999)
Nat Cell Biol
, vol.1
, pp. 113-118
-
-
Kobayashi, T.1
Beuchat, M.H.2
Lindsay, M.3
Frias, S.4
Palmiter, R.D.5
Sakuraba, H.6
Parton, R.G.7
Gruenberg, J.8
-
12
-
-
0032510559
-
A lipid associated with the antiphospholipid syndrome regulates endosome structure and function
-
Kobayashi T. Stang E. Fang K. S. (1998). A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 392, 193–7.
-
(1998)
Nature
, vol.392
, pp. 193-197
-
-
Kobayashi, T.1
Stang, E.2
Fang, K.S.3
-
13
-
-
25444443570
-
Principles of lysosomal membrane digestion: Stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids
-
Kolter T. Sandhoff K. (2005). Principles of lysosomal membrane digestion: Stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol 21, 81–103.
-
(2005)
Annu Rev Cell Dev Biol
, vol.21
, pp. 81-103
-
-
Kolter, T.1
Sandhoff, K.2
-
14
-
-
77951924919
-
Lysosomal degradation of membrane lipids
-
Kolter T. Sandhoff K. (2010). Lysosomal degradation of membrane lipids. FEBS Lett 584, 1700–12.
-
(2010)
FEBS Lett
, vol.584
, pp. 1700-1712
-
-
Kolter, T.1
Sandhoff, K.2
-
16
-
-
0024563279
-
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
-
Lewis J. H. Ranard R. C. Caruso A. Jackson L. K. Mullick F. Ishak K. G. Seeff L. B. Zimmerman H. J. (1988). Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients. Hepatology 9, 679–85.
-
(1988)
Hepatology
, vol.9
, pp. 679-685
-
-
Lewis, J.H.1
Ranard, R.C.2
Caruso, A.3
Jackson, L.K.4
Mullick, F.5
Ishak, K.G.6
Seeff, L.B.7
Zimmerman, H.J.8
-
17
-
-
0034158443
-
Niemann-Pick type C mutations cause lipid traffic jam
-
Liscum L. (2000). Niemann-Pick type C mutations cause lipid traffic jam. Traffic 1, 218–25.
-
(2000)
Traffic
, vol.1
, pp. 218-225
-
-
Liscum, L.1
-
18
-
-
4944230810
-
Intracellular trafficking of Niemann-Pick C proteins 1 and 2: Obligate components of subcellular lipid transport
-
Liscum L. Sturley S. L. (2004). Intracellular trafficking of Niemann-Pick C proteins 1 and 2: Obligate components of subcellular lipid transport. Biochim Biophys Acta 1685, 22–7.
-
(2004)
Biochim Biophys Acta
, vol.1685
, pp. 22-27
-
-
Liscum, L.1
Sturley, S.L.2
-
19
-
-
0018767532
-
Drug-induced lysosomal storage disorders
-
Lüllmann-Rauch R. (1979). Drug-induced lysosomal storage disorders. Frontiers of Biology 48, 49–130.
-
(1979)
Frontiers of Biology
, vol.48
, pp. 49-130
-
-
Lüllmann-Rauch, R.1
-
20
-
-
0034988887
-
Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane
-
Lusa S. Blom T. S. Eskelinen E. L. Kuismanen E. Månsson J. E. Simons K. Ikonen E. (2001). Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J Cell Sci 114, 1893–900.
-
(2001)
J Cell Sci
, vol.114
, pp. 1893-1900
-
-
Lusa, S.1
Blom, T.S.2
Eskelinen, E.L.3
Kuismanen, E.4
Månsson, J.E.5
Simons, K.6
Ikonen, E.7
-
21
-
-
0017762849
-
Studies on drug-induced lipidosis. VIII. Correlation between drug accumulation and acidic phospholipids
-
Matsuzawa Y. Yamamoto A. Adachi S. Nishikawa M. (1977). Studies on drug-induced lipidosis. VIII. Correlation between drug accumulation and acidic phospholipids. J Biochem 5, 1369–77.
-
(1977)
J Biochem
, vol.5
, pp. 1369-1377
-
-
Matsuzawa, Y.1
Yamamoto, A.2
Adachi, S.3
Nishikawa, M.4
-
22
-
-
59249090675
-
A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase
-
Mesens N. Steemans M. Hansen E. Peeters A. Verheyen G. Vanparys P. (2009). A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase. Toxicol In Vitro 23, 217–26.
-
(2009)
Toxicol In Vitro
, vol.23
, pp. 217-226
-
-
Mesens, N.1
Steemans, M.2
Hansen, E.3
Peeters, A.4
Verheyen, G.5
Vanparys, P.6
-
23
-
-
77953615177
-
Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays
-
Mesens N. Steemans M. Hansen E. Verheyen G. R. Van Goethem F. Van Gompel J. (2010). Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays. Toxicol In Vitro 24, 1417–25.
-
(2010)
Toxicol In Vitro
, vol.24
, pp. 1417-1425
-
-
Mesens, N.1
Steemans, M.2
Hansen, E.3
Verheyen, G.R.4
Van Goethem, F.5
Van Gompel, J.6
-
26
-
-
70249111877
-
Tissue-specific, non-invasive toxicity biomarkers: Translation from preclinical safety assessment to clinical safety monitoring
-
Muller P. Y. Dieterle F. (2009). Tissue-specific, non-invasive toxicity biomarkers: Translation from preclinical safety assessment to clinical safety monitoring. Expert Opin Drug Metab Toxicol 5, 1023–38.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 1023-1038
-
-
Muller, P.Y.1
Dieterle, F.2
-
27
-
-
34547904254
-
In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies
-
Nioi P. Perry B. K. Wang E. J. Gy Y. Z. Snyder R. D. (2007). In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol Sci 99, 162–73.
-
(2007)
Toxicol Sci
, vol.99
, pp. 162-173
-
-
Nioi, P.1
Perry, B.K.2
Wang, E.J.3
Gy, Y.Z.4
Snyder, R.D.5
-
28
-
-
42949117040
-
Drug-induced phospholipidosis—pathological aspects and its prediction
-
Nonoyama T. Fukuda R. (2008). Drug-induced phospholipidosis—pathological aspects and its prediction. J Toxicol Pathol 21, 9–24.
-
(2008)
J Toxicol Pathol
, vol.21
, pp. 9-24
-
-
Nonoyama, T.1
Fukuda, R.2
-
29
-
-
84992874186
-
Phospholipidosis in healthy subjects participating in clinical studies: Ultrastructural findings in white blood cells
-
[Epub ahead of print]
-
Pospischil A. Walther P. Dingemanse J. (2009). Phospholipidosis in healthy subjects participating in clinical studies: Ultrastructural findings in white blood cells. Exp Toxicol Pathol 10 [Epub ahead of print].
-
(2009)
Exp Toxicol Pathol
, vol.10
-
-
Pospischil, A.1
Walther, P.2
Dingemanse, J.3
-
30
-
-
33749128073
-
Drug-induced phospholipidosis: Issues and future directions
-
Reasor M. J. Hasting K. L. Ulrich R. G. (2006). Drug-induced phospholipidosis: Issues and future directions. Expert Opin Drug Saf 5, 567–83.
-
(2006)
Expert Opin Drug Saf
, vol.5
, pp. 567-583
-
-
Reasor, M.J.1
Hasting, K.L.2
Ulrich, R.G.3
-
31
-
-
0035687129
-
Drug-induced phospholipidosis: Are there functional consequences?
-
Reasor M. J. Kacew S. (2001). Drug-induced phospholipidosis: Are there functional consequences? Exp Biol Med 226, 825–30.
-
(2001)
Exp Biol Med
, vol.226
, pp. 825-830
-
-
Reasor, M.J.1
Kacew, S.2
-
32
-
-
0030025618
-
Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats
-
Reasor M. J. McCloud C. M. Beard T. L. Ebert D. C. Kacew S. Gardner M. F. Aldern K. A. Hostetler K. Y. (1996). Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats. Toxicology 106, 139–47.
-
(1996)
Toxicology
, vol.106
, pp. 139-147
-
-
Reasor, M.J.1
McCloud, C.M.2
Beard, T.L.3
Ebert, D.C.4
Kacew, S.5
Gardner, M.F.6
Aldern, K.A.7
Hostetler, K.Y.8
-
33
-
-
51249190317
-
Accumulation of a glycerolphospholipid in classical Niemann-Pick disease
-
Rouser G. Kritchevsky G. Knudson A. G. Jr Simon G. (1968). Accumulation of a glycerolphospholipid in classical Niemann-Pick disease. Lipids 3, 287–90.
-
(1968)
Lipids
, vol.3
, pp. 287-290
-
-
Rouser, G.1
Kritchevsky, G.2
Knudson, A.G.3
Simon, G.4
-
34
-
-
63149196645
-
Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation
-
Schulze H. Kolter T. Sandhoff K. (2009). Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation. Biochim Biophys Acta 1793, 674–83.
-
(2009)
Biochim Biophys Acta
, vol.1793
, pp. 674-683
-
-
Schulze, H.1
Kolter, T.2
Sandhoff, K.3
-
35
-
-
77951288434
-
Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities
-
Tengstrand E. A. Miwa G. T. Hsieh F. Y. (2010). Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities. Expert Opin Drug Metab Toxicol 6, 555–70.
-
(2010)
Expert Opin Drug Metab Toxicol
, vol.6
, pp. 555-570
-
-
Tengstrand, E.A.1
Miwa, G.T.2
Hsieh, F.Y.3
-
36
-
-
33750928793
-
Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential
-
Tomizawa K. Sugano K. Jamada H. Horii I. (2006). Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential. J Toxicol Sci 31, 315–24.
-
(2006)
J Toxicol Sci
, vol.31
, pp. 315-324
-
-
Tomizawa, K.1
Sugano, K.2
Jamada, H.3
Horii, I.4
-
37
-
-
0015026428
-
Drug-induced lipidosis in human cases and in animal experiments. Accumulation of an acidic glycerophospholipid
-
Yamamoto A. Adachi S. Kitani T. Shinji Y. Seki K. (1971). Drug-induced lipidosis in human cases and in animal experiments. Accumulation of an acidic glycerophospholipid. J Biochem 69, 613–5.
-
(1971)
J Biochem
, vol.69
, pp. 613-615
-
-
Yamamoto, A.1
Adachi, S.2
Kitani, T.3
Shinji, Y.4
Seki, K.5
|